Renal Diseases Market Reports Empesis on Targeting Immune and Hormone Signaling Dominating the Pipeline for Chronic Kidney Disease

The Frontier Pharma: Renal Diseases High Degree of Innovation and Diversity with Products Targeting Immune and Hormone Signaling Dominating the Pipeline for Chronic Kidney Disease assesses first-in-class innovation in the renal diseases pipeline, highlighting key trends and emerging treatment classes.

Pune, India - March 14, 2018 /MarketersMedia/ —

The renal diseases therapy area encompasses a range of diseases of the kidney, such as chronic kidney disease (CKD), acute kidney injury, diabetic nephropathy and focal segmental glomerulosclerosis. Renal diseases are becoming increasingly common due to the increased prevalence of hypertension and diabetes, two major causes of CKD. For most forms of renal diseases, early detection and management may slow down or prevent progression to renal failure and associated complications. However, many renal diseases are typically asymptomatic until they have progressed to end-stage renal disease (ESRD), which requires renal replacement therapies such as hemodialysis and renal transplantation, and is associated with substantial morbidity and mortality.

Access Report Details at: https://www.themarketreports.com/report/frontier-pharma-renal-diseases-high-degree-of-innovation-and-diversity-with-products-targeting-immune-and-hormone-signaling-dominating-the-pipeline-for-chronic-kidney-disease

The first-in-class programs identified show considerable diversity, and the relatively high degree of innovation in the renal diseases therapy area makes for a promising development pipeline. It is clear that recent activity in this area has increased, partly owing to the growing recognition of the unmet medical need. Further investment in innovation would benefit the therapy area greatly, and likely prove a worthwhile investment, particularly for highly prevalent diseases such as CKD and diabetic nephropathy, for which there are a lack of effective pharmacotherapeutic options.

Get this report at: https://www.themarketreports.com/report/buy-now/935551

Scope
• With 365 products in active development, the pipeline is modestly sized. Does current pipeline innovation hold the potential to affect the future renal diseases market?
• There are 100 first-in-class products in the renal diseases pipeline. Which of these hold the greatest potential to improve future disease treatment with regard to their molecular target?
• The majority of first-in-class products were in development for indications involving inflammation. Which first-in-class targets are most promising, and how does the ratio of first-in-class targets to first-in-class products differ by stage of development and molecular target class?
• A significant number of first-in-class products have been identified with no prior involvement in deals. How do deal frequency and value compare between target families and molecule types, and which first-in-class programs have not yet been involved in a licensing or co-development deal?

Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/935551

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/renal-diseases-market-reports-empesis-on-targeting-immune-and-hormone-signaling-dominating-the-pipeline-for-chronic-kidney-disease/314328

For more information, please visit https://www.themarketreports.com/report/frontier-pharma-renal-diseases-high-degree-of-innovation-and-diversity-with-products-targeting-immune-and-hormone-signaling-dominating-the-pipeline-for-chronic-kidney-disease%20%20

Source: MarketersMedia

Release ID: 314328

Latest News

Mother of sick boy seeks legalization of medical marijuana

Jun 18, 2018

LONDON — The mother of an epileptic boy at the center of a debate over medical marijuana in the U.K. is calling for an urgent meeting with ministers to discuss liberalizing British policy. Charlotte Caldwell said Sunday she also wants assurances from the government that her 12-year-old son Billy will be able to keep receiving cannabis oil once a 20-day emergency supply approved by the government runs out. Caldwell wants to make sure there isn't "another battle" over the medicine that she believes has warded off potentially life-threatening seizures for her son. Billy remains hospitalized in London for severe seizures...

UK changes course, allows epileptic boy to use cannabis oil

Jun 18, 2018

LONDON — The British government changed course Saturday in a case concerning cannabis oil, saying an epileptic boy can be treated with it after his mother said he needed it to survive severe seizures. Home Secretary Sajid Javid said he has agreed to urgently issue a license to allow Billy Caldwell, a 12-year-old from Northern Ireland, to be treated with the oil. He said his decision was based on advice from senior doctors who say that Caldwell, who was hospitalized overnight in London, faces a medical emergency. Javid said the British government's immediate priority was to make sure Caldwell receives...

Beloved Glasgow School of Art badly damaged by a 2nd fire

Jun 18, 2018

LONDON — Glasgow has suffered a major blow as a second severe fire in four years has gutted the historic Glasgow School of Art, one of the Scottish city's most beloved cultural treasures. Fire officials said Saturday the fire was mostly under control and that there seemed to be no casualties, but said that every floor of the historic building at the heart of the city center was damaged. The cause of the fire has not been established. It came near the end of a multimillion pound (dollar) project to restore the building to its former glory after a 2014...

Famed Glasgow art school ravaged by fire again

Jun 18, 2018

LONDON — A large blaze ripped through an architecturally important building at the Glasgow School of Art, the second time in four years that fire has damaged the famed Scottish school. More than 60 firefighters were battling the blaze early Saturday morning, and images posted on social media showed flames and smoke billowing from the roof of the Glasgow School of Art's Mackintosh Building. Scottish First Minister Nicola Sturgeon said she was heartbroken by the fire, tweeting: "This is clearly an extremely serious situation. My first thoughts tonight are for the safety of people - but my heart also breaks...

Stephen Hawking's ashes buried in Westminster Abbey

Jun 18, 2018

LONDON — The ashes of Stephen Hawking were buried Friday in a corner of Westminster Abbey that honors some of Britain's greatest scientists, between the graves of Charles Darwin and Isaac Newton. More than 1,000 people attended a service of thanksgiving in the ancient abbey for the physicist, who died in March at age 76 after decades of living with motor neuron disease. When he was diagnosed, aged 22, he was given only a few years to live. Hawking conducted groundbreaking research into black holes and the origins of the universe, and gained global fame as a popularizer and communicator...

Sign up now!